H
Hao Shi
Researcher at Zhengzhou University
Publications - 36
Citations - 167
Hao Shi is an academic researcher from Zhengzhou University. The author has contributed to research in topics: Medicine & Blastocyst Transfer. The author has an hindex of 4, co-authored 22 publications receiving 58 citations.
Papers
More filters
Journal ArticleDOI
The Relationship Between Serum Delta FSH Level and Ovarian Response in IVF/ICSI Cycles
TL;DR: There is a weak relationship between ovarian response and serum delta FSH levels, and the tertile statistics to divide the groups.
Journal ArticleDOI
The single-nucleotide polymorphism rs743572 of CYP17A1 shows significant association with polycystic ovary syndrome: a meta-analysis
TL;DR: The rs743572 T>C mutation was most likely to be associated with PCOS risk under the recessive model, and the mutant genotype CC may increase susceptibility to PCOS in Caucasians rather than Asians.
Journal ArticleDOI
The Combined Impact of Female and Male Body Mass Index on Cumulative Pregnancy Outcomes After the First Ovarian Stimulation
Zhonghua Zhao,Xue Jiang,Jing Li,Menghui Zhang,Jinhao Liu,Shanjun Dai,Hao Shi,Yu-Ling Liang,Li Yang,Yihong Guo +9 more
TL;DR: In this paper, the authors evaluated the combined impact of male and female BMI on cumulative pregnancy outcomes after the first ovarian stimulation and concluded that the cumulative live birth rate is negatively impacted by increased BMI in the female and overweight status in the male, both individually and together.
Journal ArticleDOI
Gene Spectrum and Clinical Traits of Nine Patients With Oocyte Maturation Arrest
TL;DR: The related pathogenic mutations of the PATL2, TUBB8, and ZP1∼3 genes were highly suggestive of being causative of oocyte maturation arrest, enabling the expansion of the gene variant spectrum.
Journal ArticleDOI
Efficacy and Safety of In Vitro Fertilization (IVF)/Intracytoplasmic Sperm Injection (ICSI) Among Patients with Endometriosis After a Shortened Protocol of Long-Term Pituitary Downregulation.
TL;DR: It was showed that the shortened regimen and the ultralong regimen did not produce different pregnancy outcomes after ART, and the single-application, long-term GnRH-a protocol may serve as a cost-effective and safe treatment protocol for EMs patients.